Search by Drug Name or NDC
NDC 00404-9977-20 Xylocaine .01; 10 mg/mL; mg/mL Details
Xylocaine .01; 10 mg/mL; mg/mL
Xylocaine is a INFILTRATION; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Henry Schein, Inc.. The primary component is EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS.
Product Information
| NDC | 00404-9977 |
|---|---|
| Product ID | 0404-9977_4bec9662-8e1f-4e9c-9ea9-c67fd4bf11be |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Xylocaine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine Hydrochloride and Epinephrine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INFILTRATION; PERINEURAL |
| Active Ingredient Strength | .01; 10 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Labeler Name | Henry Schein, Inc. |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA006488 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00404-9977-20 (00404997720)
| NDC Package Code | 0404-9977-20 |
|---|---|
| Billing NDC | 00404997720 |
| Package | 1 VIAL in 1 BAG (0404-9977-20) / 20 mL in 1 VIAL |
| Marketing Start Date | 2022-01-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |